Navigation Links
UC Berkeley launches Synthetic Biology Institute to advance research in biological engineering
Date:4/21/2011

ritical societal needs. Researchers are employing synthetic biology to develop inexpensive, plentiful drugs for treating the world's most intractable diseases, viable methods for producing transportation biofuels from plants, microbes that target tumors and disease, and an array of other applications, including water purification, agricultural advances, environmental remediation, and the creation of functional new materials.

"Synthetic biology potentially can have as profound an impact in the 21st century as semiconductor technology had in the 20th," said William P. Sullivan, Agilent's CEO and president. "To get there, we need to engineer biological solutions that are scalable, reliable, and safe. This is precisely what the UC Berkeley Synthetic Biology Institute is addressing, and why Agilent is enthusiastic about providing infrastructure, expertise, and funding for this new institute."

The deans of the two UC Berkeley colleges that have launched SBI S. Shankar Sastry of the College of Engineering and Richard A. Mathies of the College of Chemistry lauded Agilent's substantial commitment to SBI and its leadership in supporting the new endeavor. They are working to attract other industry members who will follow Agilent's lead, lending both financial support and research-area expertise, while advancing each company's own business goals in developing synthetic biology.

SBI is broadly interdisciplinary, with 33 faculty and scientists from eight academic departments at Berkeley and four divisions at LBNL, spanning engineering, chemical sciences, and biology.

Key research goals are to deepen understanding of how biological systems work; develop robust, transferable tools to engineer biosystems reliably; and develop and disseminate standardized design rules for constructing biological components and systems for diverse applications. Analyzing and addressing the ethical and social impacts of synthetic biology are also a focus for the
'/>"/>

Contact: Tom Gray
tsgray@pontifexmarketing.com
805-927-4402
Pontifex Marketing and Communications
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Nanyang Technological University and University of California, Berkeley pursue research alliance
2. Berkeley Lab lends expertise to India to promote energy efficiency
3. Berkeley Lab researchers participate in Homeland Security study of subway airflow
4. Berkeley scientists find new way to get physical in the fight against cancer
5. Berkeley Lab to build DOE advanced biofuels user facility
6. Berkeley Lab researchers illuminate laminins role in cancer formation
7. Getting organized: Berkeley Lab study shows how breast cell communities organize into breast tissue
8. Berkeley Lab researchers make first perovskite-based superlens for the infrared
9. The Rett Syndrome Research Trust launches operations
10. LIAI launches new division to look at novel approaches to heart disease and inflammation
11. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
(Date:8/5/2015)... 2015 According to a new ... Software, Services, Vertical (BFSI, Airport, IT & Telecom, Utilities, ... Forecast to 2020", published by MarketsandMarkets, defines and segments ... various segments. The global PIAM Market is estimated to ... by 2019, at a CAGR of 14.9 % from ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. ... interface solutions, today announced that members of the executive ... the Pacific Crest Global Technology Leadership Forum on Tuesday, ... conference will be held at the Sonnenalp Resort in ... The presentation may include forward-looking information. An audio webcast ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... which trauma and burn patients are most likely to ... range of experimental clinical settings ?an important hurdle to ... rooms and intensive care units. , In a report ... National Academy of Sciences, researchers from eight institutions, including ...
... of California, San Diego (UCSD) have found that Lafora disease, ... the age of 30, can be caused by mutations in ... These findings are reported in the current issue of Proceedings ... is characterized by normal development for the first decade of ...
... comparing, for the first time, breast cancers from Nigeria, ... African ancestry are more likely to be diagnosed with ... of European ancestry. , Researchers from the University of ... in Nigeria and the University of North Carolina, found ...
Cached Biology News:Doctors closer to using gene analysis to help trauma patients 2Doctors closer to using gene analysis to help trauma patients 3UCSD research reveals mechanism involved with type of fatal epilepsy 2Study reveals dramatic difference between breast cancers in US and Africa 2Study reveals dramatic difference between breast cancers in US and Africa 3Study reveals dramatic difference between breast cancers in US and Africa 4
(Date:8/31/2015)... BALTIMORE , Aug. 31, 2015  For people ... may brighten their day. The biotechnology company, located in ... outlined one of the best potential therapies yet for ... paper entitled, " Correction of Down syndrome and Edwards ... the journal DNA Research . Elixirgen plans to ...
(Date:8/31/2015)... HAYWARD, Calif. and SHANGHAI ... Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, ... Phase 2 clinical study for its lead drug ... designed to treat drug-resistant bacteria such as MRSA ... safer and better tolerated therapeutic option than currently ...
(Date:8/31/2015)... ... August 31, 2015 , ... Regulatory agencies have acknowledged ... development approval process. Thus, innovator companies must understand what will be needed in ... CMO, has been hosting multiple educational panels and seminars for experts to share ...
(Date:8/30/2015)... , England , August 31, ... beendet die 51-jährige Wartezeit   einer Frau   für ... Frauen im Alter von 7-90   werden ... Programm soll 1200 Frauen behandeln und die ... , Astellas gab heute bekannt, ...
Breaking Biology Technology:New Down syndrome therapy discovered 2MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5
... Colo., Sept. 25 Steve Pettit, Director of,the ... http://www.InVitria.com ) Cellastim in mammalian cell culture at ... week., "Cellastim showed superior results compared to ... 50% improvement in productivity in CHO cell,lines using ...
... in Complement Inhibition and,Impact of Soliris on Patients ... Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ) has ... Biotechnology Product for Soliris(R) (eculizumab). The Award,recognizes the ... and the impact the drug is,having on the ...
... Net Income of $27 to $28 ... ... Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), ... China ("PRC"), today announced that it,has increased its revenue and earnings guidance ...
Cached Biology Technology:InVitria's Cellastim Delivers Superior Results in Mammalian Cell Culture 2Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 2Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 3Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 4Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 5China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 2China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 3
...
... Suite for Mac OS X provides the ... and protein sequence analysis and molecular biology ... (Table 1). With Vector NTI Suite you ... and publicize diverse types of molecular biology ...
...
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
Biology Products: